NGAL Polyclonal Antibody and 1 more item

The University of Virginia awarded a purchase order (A207_PO-0448774) to Life Technologies Corporation on June 13, 2026, for laboratory reagents and research supplies totaling $1,319.25. The contract encompasses two distinct line items: one NGAL (Neutrophil Gelatinase-Associated Lipocalin) polyclonal antibody unit priced at $353.25, and two RevertAid H Minus First Strand complementary deoxyribonucleic acid (cDNA) Synthesis Kits at $483.00 each, representing 100 reactions per kit. Both items are designated for delivery to Michael James Freeman at the University of Virginia.

This procurement represents a straightforward materials purchase agreement for molecular biology and immunological research supplies within the Commonwealth of Virginia. As a single purchase order award, the contract establishes a cumulative value of $1,319.25 with no identified ongoing annual value or extended performance period. The reagents supplied are consistent with standard life sciences research applications, supporting protein detection and nucleic acid synthesis capabilities for the University of Virginia's research operations.